A recently published study showed that administration of one type of compounded omeprazole suspension was ineffective in healing ulcers in racehorses, while treatment with the FDA-approved form of omeprazole (GastroGard) was effective in attenuating ulcers. The study was completed at the University of California, Davis, and appeared in the latest issue of the Journal of the American Veterinary Association (https://www.avma.org). Findings show that horse owners trying to save money by using the particular compound used in the study aren’t helping their horses, and should spur horse owners to find out what’s in compounded medications they purchase.
COURTESY UC DAVIS CENTER FOR EQUINE HEALTH
Endoscopic views of the same horse exhibiting severe stomach ulcers at pre-trial examination (left), significant healing after 30 days of treatment with GastroGard (center), and the recurrence of ulcers after treatment was switched to compounded omeprazole for an additional 30 days (right).
Jack Snyder, DVM, PhD, chief of equine surgery and lameness at the University of California, Davis, and his research team that included Jorge E. Nieto, MVZ, Dipl. ACVS, title author on the study, scoped 44 Thoroughbreds in training at Golden Gate Fields in San Francisco, Calif. Of the 44, the researchers chose the 32 horses which had the high